University of Texas MD Anderson Cancer Center Dept of MD Anderson (16) — Houston, Texas

University of Texas MD Anderson Cancer Center Dept of MD Anderson (16) is a clinical research site located in Houston, Texas, United States 77030.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

University of Texas MD Anderson Cancer Center Dept of MD Anderson (16) has participated in 2 clinical trials.

Therapeutic areas: Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Texas MD Anderson Cancer Center Dept of MD Anderson (16)?

University of Texas MD Anderson Cancer Center Dept of MD Anderson (16) has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Texas MD Anderson Cancer Center Dept of MD Anderson (16) conducted?

University of Texas MD Anderson Cancer Center Dept of MD Anderson (16) has 2 clinical trials on record. Their work covers Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia.

Is University of Texas MD Anderson Cancer Center Dept of MD Anderson (16) accredited by Crixeo Health?

University of Texas MD Anderson Cancer Center Dept of MD Anderson (16) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Texas MD Anderson Cancer Center Dept of MD Anderson (16)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.